Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Clostridium Difficile-Associated Diarrhea Clinical Trials

A listing of Clostridium Difficile-Associated Diarrhea medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (17) clinical trials

Spending a lot of time at the doctor? Learn about a study of an investigational vaccine for people who may be at risk of Clostridium difficile (C. Diff). People who are taking antibiotics or are being treated at a hospital or health care facility have an increased chance of getting ...

Phase N/A

Research study of an Investigational vaccine for the potential prevention of primary C-difficile infection.

Phase

Is another Clostridium difficile infection getting in the way of your life? Consider this medical research study of an investigational medication that may help prevent these infections from recurring.

Phase N/A

Wake Research Associates is enrolling volunteers with C. Diff in a study testing the effectiveness, tolerability and safety of an investigational medication for this condition. Some of the symptoms of C. diff infection include: Watery diarrhea, up to 15 times each day Severe abdominal pain Loss of appetite Fever Blood ...

Phase N/A

Carolina’s GI Research is enrolling volunteers with C. Diff in a study testing the effectiveness, tolerability and safety of an investigational medication for this condition.

Phase N/A

Qualified participants will receive at no cost to them: study medications study-related labs physicals and exams compensation for your time and travel for each visit

Phase N/A

The Clover trial is evaluating an investigational vaccine that may help to prevent Clostridium difficile infection. Participants in the study are adults 50 years of age and older, who are at risk of developing Clostridium difficile infection. The study will assess whether the vaccine prevents the disease, and whether it ...

Phase

Meridien Research is seeking research volunteers for a study being conducted to evaluate the effects of an investigational vaccine for C. Diff infections.

Phase N/A

Individuals most at-risk for C. diff have a generally weakened condition, have received antibiotics, and are likely to have been hospitalized or residing in Long Term Care Facilities. Clostridium difficile (C-diff) is a potentially deadly, spore-forming bacterium emerging as the leading cause of life-threatening, healthcare-associated infections worldwide. C.diff toxins cause ...

Phase

The aim of this study is to evaluate the efficacy of the candidate Clostridium difficile (C. difficile) vaccine to prevent primary symptomatic C. difficile infection (CDI) in subjects a risk for CDI where there is a substantial unmet medical need.

Phase